Every year during the holidays, the SVA team stops to reflect on the joy and blessings in their lives, while also being aware...

In a rapid launch, the process behind getting started can often be intimidating and lead to chaos and confusion. Simplify it...

SVA Life Sciences is proud to announce the firm will be an exhibitor at the 2022 World Orphan Drug Congress held on July 11-13,...

SVA Life Sciences, a division of SVA Consulting, is pleased to announce that Sara’s Cure (DBA Clear Cell Sarcoma Foundation) has...

Your biopharma company is evolving. You have increased headcount, M&A activity, clinical activity, outsourcing activities or need...

As a first-time launcher, the ability to quickly identify hurdles and take action through this exciting and turbulent time is...

One of the key learnings from successful product launches is that successful launch teams relentlessly measure performance and...

Your emerging organization is getting ready to launch your first product and is eagerly anticipating recognizing revenue for that...

Think your Biopharma startup is “too small” for cybersecurity risk? We see it all the time. Read these real cybersecurity breach...

In the first critical months a biopharmaceutical product is in-market, stakeholders need accessible, reliable information to make...